Benjamin Bridges1, Arif Hussain
1Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Germ cell tumors are highly treatable, but challenges remain for recurrent disease. Ongoing research into molecular pathogenesis and risk-adapted therapies aims to improve outcomes for all patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: